Drug recall D-0771-2021
Product
Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by Thymoorgan Pharmazie GmbH Schiffgraben 23, 38690 Gosfar, Germany Distributed by Hikma USA Inc. Berkeley Heights, NJ 07922, NDC 0143-9240-01
Reason for recall
Labeling: Not elsewhere classified: Mislabeling
Lots and codes
BL0018
Recall details
- Recalling firm
- Hikma Pharmaceuticals USA Inc., Cherry Hill, NJ
- Quantity
- 1,152 vials
- Distribution
- USA nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 5, 2021
- Terminated
- June 8, 2023
Related products
- Bleomycin – drug information
- NDC 0143-9240 Bleomycin · Bleomycin Sulfate 15 [USP'U]/1 · Hikma Pharmaceuticals USA Inc.
- NDC 0143-9241 Bleomycin · Bleomycin Sulfate 30 [USP'U]/1 · Hikma Pharmaceuticals USA Inc.